| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.078 | 0.1 |